AndrewAHertlerMD

Oncology • Augusta, ME

Administrative Medical Director Physician Practices

Join to view full profile

Dr. Hertler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hertler's full profile

Already have an account?

Office
361 Old Belgrade Rd
Alfond Cancer Center
Augusta, ME 04330
Phone+1 207-621-6100

Fax+1 207-621-6102

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 1985 - 1988
University of MichiganResidency, Internal Medicine, 1982 - 1984
University of Michigan Medical SchoolClass of 1982

Certifications & Licensure

ME State Medical License 1996 - 2026
NH State Medical License 2020 - 2026
KY State Medical License 2019 - 2025
MO State Medical License 2018 - 2025
NJ State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain Start of enrollment: 2011 May 01
Unknown status
Phase 2

Publications & Presentations

Lectures

How Are Payers Using Big Data and Predictive Analytics?
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare Through Federal Oncology Care ModelMarch 10th, 2022
FDA Panel Largely Backs Speedy Cancer Drug Approvals, Forcing Tough Choice for AgencyApril 30th, 2021
Genentech Defends Breast Cancer Drug a Decade After Avastin DramaApril 27th, 2021
Join now to see all